Year-to-date low. It has been announced that the 1st unsecured ordinary corporate bonds (private placement bonds) and 130,000 stock acquisition rights will be issued. The ratio of the number of potential shares (13 million shares) to the total number of issued shares is 40.46%, and sales are dominant due to concerns about future dilution. The raised funds of 1,427 billion yen will be used for corporate bond reimbursement funds and development funds for the glaucoma treatment agent “H-1337.” The remaining 1st unsecured convertible corporate bond type corporate bonds with stock acquisition rights are redeemed, and the remaining 11th stock acquisition rights are also acquired and cancelled.
ＤＷＴＩ---年初来安値、無担保社債と新株予約権発行、調達資金14億円は償還や開発資金に充当
DWTI - year-to-date low, issuance of unsecured corporate bonds and stock acquisition rights, 1.4 billion yen of raised funds used for reimbursement and development funds
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.